The Journal of Immunology, Vol 147, Issue 9 3072-3079, Copyright © 1991 by American Association of Immunologists

ARTICLES

Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists

WA Lynn, CR Raetz, N Qureshi and DT Golenbock
Department of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston City Hospital, Boston University School of Medicine, MA 02118.

Gram-negative bacterial septicemia is a common clinical syndrome resulting, in part, from the activation of phagocytic leukocytes by LPS. By using flow cytometry, we have characterized LPS-induced expression of the beta 2 integrin CD11b/CD18. After exposure to Salmonella minnesota R595 LPS, expression of neutrophil CD11b/CD18 is rapidly upregulated, beginning within 5 min and achieving a peak fluorescence (typically two- to threefold over base line) by 30 min. The increase in CD11b/CD18 expression was similar in kinetics and magnitude to that produced by FMLP, PMA, and human rTNF-alpha. Concentrations of LPS necessary to stimulate a response were as low as 1 ng/ml of R595 LPS; a maximal response was observed between 30 and 100 ng/ml. The upregulation of CD11b/CD18 due to LPS was not interrupted by protein synthesis inhibitors. A group of glucosamine disaccharide lipid A-like molecules: Rhodobacter sphaeroides lipid A, lipid IVA, KDO2IVA, and deacylated LPS were able to block the stimulatory effect of LPS. This inhibition was specific for the actions of LPS as stimulation of polymorphonuclear leukocytes (PMN) by FMLP, human rTNF alpha, PMA, and rewarming were not altered by the disaccharide inhibitors. PMN which were exposed to the specific disaccharide LPS antagonists and then washed, were refractory to stimulation by LPS. The monosaccharide lipid A precursor lipid X also blocked stimulation of neutrophils by LPS, although with a 100-fold reduction in potency. Unlike the disaccharide inhibitors, PMN exposed to lipid X were still responsive to LPS stimulation after washing. The PMN response to LPS was less sensitive in the absence of serum, although upregulation of CD11b/CD18 could still be seen using higher concentrations of LPS. Monoclonal antibody directed against CD14 (clone 3C10), also specifically inhibited LPS induced PMN CD11b/CD18 expression both in the presence and absence of serum. These findings support the hypothesis that LPS stimulates neutrophils by interacting with specific cellular receptors.

This article has been cited by other articles:

				E. Vachon, R. Martin, V. Kwok, V. Cherepanov, C.-W. Chow, C. M. Doerschuk, J. Plumb, S. Grinstein, and G. P. Downey CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages Blood, December 15, 2007; 110(13): 4492 - 4502. [Abstract] [Full Text] [PDF]

				S. G. Elner, H. R. Petty, V. M. Elner, A. Yoshida, Z.-M. Bian, D. Yang, and A. L. Kindzelskii TLR4 Mediates Human Retinal Pigment Epithelial Endotoxin Binding and Cytokine Expression Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4627 - 4633. [Abstract] [Full Text] [PDF]

				E.-B. Haddad, K. McCluskie, M. A. Birrell, D. Dabrowski, M. Pecoraro, S. Underwood, B. Chen, G. T. De Sanctis, S. E. Webber, M. L. Foster, et al. Differential Effects of Ebselen on Neutrophil Recruitment, Chemokine, and Inflammatory Mediator Expression in a Rat Model of Lipopolysaccharide-Induced Pulmonary Inflammation J. Immunol., July 15, 2002; 169(2): 974 - 982. [Abstract] [Full Text] [PDF]

				B. G. Yipp, G. Andonegui, C. J. Howlett, S. M. Robbins, T. Hartung, M. Ho, and P. Kubes Profound Differences in Leukocyte-Endothelial Cell Responses to Lipopolysaccharide Versus Lipoteichoic Acid J. Immunol., May 1, 2002; 168(9): 4650 - 4658. [Abstract] [Full Text] [PDF]

				B. Beutler, Xin Du, and A. Poltorak Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies Innate Immunity, August 1, 2001; 7(4): 277 - 280. [PDF]

				C. Neufert, R. K. Pai, E. H. Noss, M. Berger, W. H. Boom, and C. V. Harding Mycobacterium tuberculosis 19-kDa Lipoprotein Promotes Neutrophil Activation J. Immunol., August 1, 2001; 167(3): 1542 - 1549. [Abstract] [Full Text] [PDF]

				H. J. Strausbaugh and S. D. Rosen A Potential Role for Annexin 1 as a Physiologic Mediator of Glucocorticoid-Induced L-Selectin Shedding from Myeloid Cells J. Immunol., May 15, 2001; 166(10): 6294 - 6300. [Abstract] [Full Text] [PDF]

				R. R. Ingalls, E. Lien, and D. T. Golenbock Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2 Infect. Immun., April 1, 2001; 69(4): 2230 - 2236. [Abstract] [Full Text] [PDF]

				R. R. Ingalls, E. Lien, and D. T. Golenbock Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis Innate Immunity, October 1, 2000; 6(5): 411 - 415. [Abstract] [PDF]

				J. G. Wagner and R. A. Roth Neutrophil Migration Mechanisms, with an Emphasis on the Pulmonary Vasculature Pharmacol. Rev., September 1, 2000; 52(3): 349 - 374. [Abstract] [Full Text] [PDF]

				A. M. Soler-Rodriguez, H. Zhang, H. S. Lichenstein, N. Qureshi, D. W. Niesel, S. E. Crowe, J. W. Peterson, and G. R. Klimpel Neutrophil Activation by Bacterial Lipoprotein Versus Lipopolysaccharide: Differential Requirements for Serum and CD14 J. Immunol., March 1, 2000; 164(5): 2674 - 2683. [Abstract] [Full Text] [PDF]

				S. Li, E. Sehic, Y. Wang, A. L. Ungar, and C. M. Blatteis Relation between complement and the febrile response of guinea pigs to systemic endotoxin Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1635 - R1645. [Abstract] [Full Text] [PDF]

				J. G. Wagner, K. E. Driscoll, and R. A. Roth Inhibition of Pulmonary Neutrophil Trafficking during Endotoxemia Is Dependent on the Stimulus for Migration Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 769 - 776. [Abstract] [Full Text]

				R. R. Ingalls, B. G. Monks, R. Savedra Jr., W. J. Christ, R. L. Delude, A. E. Medvedev, T. Espevik, and D. T. Golenbock CD11/CD18 and CD14 Share a Common Lipid A Signaling Pathway J. Immunol., November 15, 1998; 161(10): 5413 - 5420. [Abstract] [Full Text] [PDF]

				R. L. Delude, A. Yoshimura, R. R. Ingalls, and D. T. Golenbock Construction of a Lipopolysaccharide Reporter Cell Line and Its Use in Identifying Mutants Defective in Endotoxin, But Not TNF-{alpha}, Signal Transduction J. Immunol., September 15, 1998; 161(6): 3001 - 3009. [Abstract] [Full Text] [PDF]

				A.G. Haslberger, H.J. Mader, M. Schmalnauer, G. Kohl, M.P. Szostak, P. Messner, U.B. Sleytr, G. Wanner, S. Furst-Ladani, and W. Lubitz Bacterial cell envelopes (ghosts) and LPS but not bacterial S-layers induce synthesis of immune-mediators in mouse macrophages involving CD14 Innate Immunity, December 1, 1997; 4(6): 431 - 441. [Abstract] [PDF]

				B. D. Freeman, Z. Quezado, F. Zeni, C. Natanson, R. L. Danner, S. Banks, M. Quezado, Y. Fitz, J. Bacher, and P. Q. Eichacker rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia J Appl Physiol, November 1, 1997; 83(5): 1467 - 1475. [Abstract] [Full Text] [PDF]

				L.A. Falk, R. McNally, P.Y. Perera, J. Kenny, and S.N. Vogel LPS-inducible responses in severe combined immunodeficiency (SCID) mice Innate Immunity, August 1, 1995; 2(4): 273 - 280. [Abstract] [PDF]

				R. L. Kitchens and R. S. Munford Enzymatically Deacylated Lipopolysaccharide (LPS) Can Antagonize LPS at Multiple Sites in the LPS Recognition Pathway J. Biol. Chem., April 28, 1995; 270(17): 9904 - 9910. [Abstract] [Full Text] [PDF]

				P. Ridings, A.C. Windsor, D.P. Rossignol, W.J. Christ, C. Blocher, B.J. Fisher, A.A. Fowler, and H.J. Sugerman A synthetic lipid A analog, B464, provides significant protection against the cardiopulmonary derangements in porcine Gram-negative sepsis Innate Immunity, April 1, 1995; 2(2): 121 - 130. [Abstract] [PDF]

				E. Lien, J. C. Chow, L. D. Hawkins, P. D. McGuinness, K. Miyake, T. Espevik, F. Gusovsky, and D. T. Golenbock A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway J. Biol. Chem., January 12, 2001; 276(3): 1873 - 1880. [Abstract] [Full Text] [PDF]